DNA & Genetics $270M RNA Drug Spinout Targets Rare Genetic CardiomyopathiesBy adminMarch 11, 20260 Avidity Biosciences found an eager buyer for its neuroscience pipeline when Novartis shelled out approximately $12 billion to acquire the…
